Prolonged infusion of gemcitabine in advanced solid tumors: A phase-I-study

By Schmid Peter   Schweigert Marcus   Beinert Thomas   Flath Bernd   Sezer Orhan   Possinger Kurt  

Investigational New Drugs, Vol. 23, Iss. 2, 2005-01 ,pp. : 139-146

Springer Publishing Company

Access to resources Recommend Favorite

Phase I Clinical Trial of Exherin (ADH-1) in Patients with Advanced Solid Tumors

By  

Current Clinical Pharmacology, Vol. 8, Iss. 1, 2013-02 ,pp. : 81-88

Bentham Science Publishers

Access to resources Recommend Favorite

Phase I dose escalation clinical trial of phenylbutyrate sodium administered twice daily to patients with advanced solid tumors

By Camacho Luis   Olson Jon   Tong William   Young Charles   Spriggs David   Malkin Mark  

Investigational New Drugs, Vol. 25, Iss. 2, 2007-04 ,pp. : 131-138

Springer Publishing Company

Access to resources Recommend Favorite

Phase I Trial of the Polyamine Analog N¹,N¹⁴-Diethylhomospermine (DEHSPM) in Patients with Advanced Solid Tumors

By Wilding George   King David   Tutsch Kendra   Pomplun Marcia   Feierabend Chris   Alberti Dona   Arzoomanian Rhoda  

Investigational New Drugs, Vol. 22, Iss. 2, 2004-04 ,pp. : 131-138

Springer Publishing Company

Access to resources Recommend Favorite

Phase I trial of three-weekly Docetaxel, Carboplatin and oral lenalidomide (Revlimid®) in patients with advanced solid tumors

By Kalmadi S.   Davis M.   Dowlati A.   O’Keefe S.   Cline-Burkhardt M.   Pelley R.   Borden E.   Dreicer R.   Bukowski R.   Mekhail T.  

Investigational New Drugs, Vol. 25, Iss. 3, 2007-06 ,pp. : 211-216

Springer Publishing Company

Access to resources Recommend Favorite